Cleveland Clinic, American Well to launch telehealth company
“The opportunity that is opening in front of us is just so vast,” said Dr. Roy Schoenberg, president and CEO of American Well, after unveiling the new venture during the Clinic’s 2019 Medical Innovation Summit at the Global Center for Health Innovation.
OUTSIDERS ARE IN: THE CLEVELAND CLINIC INNOVATION SUMMIT EVOLVES
It's been 17 years since Cleveland Clinic hosted its first Medical Innovation Summit. As the 2019 version of conference officially launches Monday morning, its organizers say this year's gathering reflects the changing landscape of healthcare innovation—not only in terms of topics, such as sessions exploring AI, augmented reality, and virtual reality—but also in terms of who's standing at the dais and who's attending.
Cleveland Diagnostics Announces FDA Breakthrough Device Designation for Novel Prostate Cancer Diagnostic Test
Cleveland Diagnostics, Inc., a clinical-stage company focused on developing next-generation diagnostic tests for the early detection of cancers, announced today that it has received FDA Breakthrough Device Designation for the IsoPSA® Assay, a novel prostate cancer diagnostic test. Published studies from multicenter prospective clinical trials suggest that the non-invasive, blood-based IsoPSA assay has significant superior diagnostic accuracy when compared to traditional prostate-specific antigen (PSA) tests in detecting high-grade prostate cancer.
Cleveland Clinic wants to double its patient population in 5 years. Can it do it?
In February 2019, Cleveland Clinic President and CEO Tom Mihaljevic announced a five-year goal that might, for a less-acclaimed health system, have seemed like pie-in-the-sky: to become "the best place for health care anywhere"—and, moreover, "the best place to work in health care."
Clearly the Clinic, which already was ranked as the No. 2 system in the country by U.S. News, wasn't content to rest on its laurels. It wanted to push further, grow faster, and change more patients' lives.
Centerline Biomedical wins $1.5 million NIH grant
Centerline Biomedical, Inc., a Cleveland Clinic spinoff company, has been awarded its third small business grant from the National Institutes of Health National Heart, Lung, and Blood Institute, with the Clinic as a subawardee, to support the company's navigation system for minimally invasive surgery.
Cleveland Clinic's Medical Innovation Summit to focus on AI, drug discovery and more
Cleveland Clinic's 17th annual Medical Innovation Summit will tackle artificial intelligence, new drug discovery, nontraditional participants and personalization in health care, with a focus on the economics of it all, according to a news release.
Cleveland Clinic’s 2019 Medical Innovation Summit to Focus on ‘Caring for Every Life Through Innovation’
Cleveland Clinic’s Medical Innovation Summit will bring more than 100 speakers and leaders from over 500 organizations and 20 countries to downtown Cleveland from Oct. 21 to 23, 2019, to focus on the task of “Caring for Every Life through Innovation.”
Makers For Vets Program Returning To Northeast Ohio
Challenge America is again bringing its Makers for Veterans program to Northeast Ohio. Teams of engineers, doctors and other "makers" will work together at St. Edward High School to forge solutions to difficulties faced by disabled military veterans.
Cleveland Clinic enters license agreement for breast cancer vaccine technology
Cleveland Clinic enters license agreement for breast cancer vaccine technology. Dr. Vincent Tuohy discusses the vaccine.
Anixa Biosciences Announces a Strategic Alliance and Licensing Agreement with Cleveland Clinic for an Innovative Breast Cancer Vaccine Technology
Anixa Biosciences, Inc. (ANIX), a biotechnology company focused on harnessing the body's immune system to fight cancer, today announced that it has established a strategic alliance and license agreement with Cleveland Clinic for an innovative breast cancer vaccine technology.